
Biochemical aspirin resistance: The inability of aspirin to produce an anticipated effect on one or more tests of platelet function, such as inhibiting the biosynthesis of thromboxane, inhibiting platelet aggregation, and causing a prolongation of the bleeding time. The rationale for this testing is the concern as to whether aspirin therapy can in a given patient help prevent a <a href="https://www.medicinenet.com/heart_attack/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">heart attack</a> or <a href="https://www.medicinenet.com/stroke_symptoms_and_treatment/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">stroke</a>.